Metraipolis › archive › dc_19ef8ac40895

Therapeutic Efficacy and Safety of Intraperitoneally Administered 211At-Labeled Gold Nanoparticles for Peritoneally Disseminated Malignancies — Europe PMC PMID:42797277

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42797277
DOI
10.3390/pharmaceutics18091102
License (as archived)
solo-consultazione
Archived
2026-10-16T06:19:41.217Z
SHA-256 of the archived text
eec1954eb7b2f4dff5a75ec650d36c44d8aa21cf367bfbb337bc3633d5b5ef13
Stable URL of this page
https://metraipolis.com/documento/dc_19ef8ac40895

How to cite

Therapeutic Efficacy and Safety of Intraperitoneally Administered 211At-Labeled Gold Nanoparticles for Peritoneally Disseminated Malignancies — Europe PMC PMID:42797277 — Europe PMC (en), https://europepmc.org/article/MED/42797277 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_19ef8ac40895 (Metraipolis archive dc_19ef8ac40895, sha256 eec1954eb7b2f4dff5a75ec650d36c44d8aa21cf367bfbb337bc3633d5b5ef13)
BibTeX
@misc{dc19ef8ac40895,
  title = {Therapeutic Efficacy and Safety of Intraperitoneally Administered 211At-Labeled Gold Nanoparticles for Peritoneally Disseminated Malignancies — Europe PMC PMID:42797277},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42797277},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_19ef8ac40895; sha256 eec1954eb7b2f4dff5a75ec650d36c44d8aa21cf367bfbb337bc3633d5b5ef13},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42797277. Agents can read the archived copy with the MCP tool read_document.